Expression of mRNA and immunoreactivity for the granulocyte/macrophage colony-stimulating factor in activated human eosinophils

J Exp Med. 1991 Sep 1;174(3):749-52. doi: 10.1084/jem.174.3.749.

Abstract

Using in situ hybridization, we have shown that activated human peripheral blood eosinophils express mRNA for granulocyte/macrophage colony-stimulating factor (GM-CSF). Between 15 and 27% of eosinophils gave positive hybridization signals for GM-CSF mRNA after stimulation with the calcium ionophore A23187 or interferon gamma, and 4 and 6% after incubation with interleukin 3 (IL-3) or IL-5. Activated eosinophils also gave specific immunoreactivity with an anti-GM-CSF polyclonal antibody, suggesting translation of the mRNA. These data indicate that eosinophils may be an important source of GM-CSF at sites of allergic inflammation. Furthermore, the identification of GM-CSF production by human eosinophils suggests that the pro-inflammatory potential of this cell type may be substantially greater than hitherto recognized.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Calcimycin / pharmacology
  • Cytokines / pharmacology
  • Eosinophils / drug effects
  • Eosinophils / physiology*
  • Gene Expression
  • Granulocyte-Macrophage Colony-Stimulating Factor / genetics*
  • Granulocyte-Macrophage Colony-Stimulating Factor / immunology
  • Humans
  • In Vitro Techniques
  • Nucleic Acid Hybridization
  • RNA, Messenger / genetics

Substances

  • Cytokines
  • RNA, Messenger
  • Calcimycin
  • Granulocyte-Macrophage Colony-Stimulating Factor